The following table reconciles the number of common shares used to compute basic and diluted earnings/(loss) per share attributable to Cardinal Health, Inc.:


	Three Months Ended December 31,
(in millions)	2022	2021
Weighted-average common shares–basic	261	279
Effect of dilutive securities:
Employee stock options, restricted share units and performance share units	—	2
Weighted-average common shares–diluted	261	281


	Six Months Ended December 31,
(in millions)	2022	2021
Weighted-average common shares–basic	266	283
Effect of dilutive securities:
Employee stock options, restricted share units and performance share units	—	2
Weighted-average common shares–diluted	266	285

The potentially dilutive employee stock options, restricted share units and performance share units that were antidilutive were 3 million and 5 million for the three and six months ended December 31, 2022, respectively. For both the three and six months ended December 31, 2022, there were 2 million potentially dilutive employee stock options, restricted share units and performance share units not included in the computation of diluted loss per common share attributable to Cardinal Health, Inc. because their effect would have been antidilutive as a result of the net loss during those periods.